Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study in Patients With Asthma

This study has been completed.
Sponsor:
Information provided by:
Dey
ClinicalTrials.gov Identifier:
NCT00215397
First received: September 13, 2005
Last updated: November 10, 2010
Last verified: February 2008

September 13, 2005
November 10, 2010
Not Provided
February 2003   (final data collection date for primary outcome measure)
The primary outcome variable is the measure of lung function.
Same as current
Complete list of historical versions of study NCT00215397 on ClinicalTrials.gov Archive Site
  • Secondary outcomes include change in lung function, as well as in vital signs.
  • Physical exams, AE reporting, etc.
Same as current
Not Provided
Not Provided
 
Study in Patients With Asthma
Not Provided

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Asthma
Drug: Formoterol Fumarate
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
December 2005
February 2003   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with a history of asthma

Exclusion Criteria:

  • Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization
  • History of smoking
  • Debilitating systemic and/or life-threatening diseases.
Both
5 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00215397
DL-053
Not Provided
Director, Clinical Affairs, Dey
Dey
Not Provided
Not Provided
Dey
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP